SLE Laboratory Findings: True Statements
Statements c) thrombocytopenia, d) leukopenia, and e) neutropenia are TRUE for systemic lupus erythematosus, while a) ESR and elevated CRP may coexist is PARTIALLY TRUE (though CRP elevation is typically modest), and b) ANA-negative with anti-Sm positive is FALSE.
Analysis of Each Statement
a) ESR and Elevated CRP May Coexist
This statement is partially true but clinically misleading. SLE characteristically shows a dissociation between ESR and CRP:
- ESR is typically elevated in active SLE and correlates with disease activity 1
- CRP remains disproportionately low during lupus flares, which is a distinctive feature of SLE 2
- When CRP is significantly elevated (>50-60 mg/L), this typically indicates superimposed infection rather than lupus activity alone 2
- The ESR:CRP ratio is actually useful diagnostically - each unit increase in ESR:CRP ratio increases odds of SLE flare versus infection by 17% 3
Clinical caveat: If you see markedly elevated CRP (>60 mg/L) in an SLE patient, strongly suspect infection or serositis rather than typical lupus activity 2.
b) ANA-Negative with Anti-Sm Positive
This statement is FALSE. This scenario is essentially impossible:
- ANA positivity (≥1:80) is now a mandatory entry criterion for SLE classification under EULAR/ACR 2019 criteria 4
- Anti-Sm antibodies are directed against nuclear antigens and would produce a positive ANA pattern 4
- Anti-Sm antibodies are highly specific for SLE but have low sensitivity 4
Bottom line: You cannot have anti-Sm antibodies without positive ANA - the anti-Sm antibodies themselves target nuclear components that would cause ANA positivity.
c) Thrombocytopenia
TRUE - This is a well-established hematological manifestation of SLE:
- Thrombocytopenia occurs in approximately 38% of SLE patients at presentation 5
- It is one of the four cytopenias included in EULAR/ACR classification criteria 1
- Thrombocytopenia correlates with anti-dsDNA antibodies (OR=5.269) and antiphospholipid antibodies 6, 7
- Associated with leukopenia, elevated ESR, and neuropsychiatric manifestations 6
d) Leukopenia
TRUE - This is a common and prognostically significant finding:
- Leukopenia (typically defined as <10,000/mm³ or <15,000/mm³ depending on criteria) is a frequent manifestation 1
- Present in 92% of patients in some cohorts 5
- Associated with C3/C4 hypocomplementemia and anti-Ro/SSA antibodies (OR=8.888) 7
- Negatively associated with lupus nephritis and lupus anticoagulant 7
- Severe neutropenia (<500 cells/mm³) increases infection risk and requires monitoring 8
e) Neutropenia
TRUE - Neutropenia is part of the leukopenia spectrum in SLE:
- Neutropenia with >80% neutrophils occurs in approximately 39-51% of patients 9
- Severe neutropenia (<500 cells/mm³) is a specific risk factor for infection that requires continuous monitoring 8
- Part of the hematological abnormalities that correlate with disease prognosis 1
Summary Algorithm for Hematological Monitoring
At baseline, check: CBC with differential, looking specifically for:
- Anemia (present in 98% of cases) 5
- Leukopenia (92% of cases) 5
- Lymphopenia (85% of cases) 5
- Thrombocytopenia (38% of cases) 5
During follow-up: CBC should be monitored regularly as these parameters provide prognostic information and correlate with disease activity 1, 8.